Barchart.com
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Trevi Therapeutics Inc (TRVI)

Trevi Therapeutics Inc (TRVI)
6.02 -0.08 (-1.31%) 15:21 ET [NASDAQ]
6.02 x 70 6.03 x 102
Realtime by (Cboe BZX)
6.02 x 70 6.03 x 102
Realtime - - (-) -
News & Headlines for Thu, Apr 17th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board GlobeNewswire - Wed Mar 26, 6:00AM CDT

BHVN : 19.98 (+6.96%)
COLL : 27.08 (+0.22%)
TRVI : 6.02 (-1.31%)
AVTX : 4.61 (-0.43%)
Retail Chatter For Trevi Therapeutics Soars After Enrollment Target For Chronic Cough Study Hits 75% Stocktwits - Fri Dec 13, 2024

An independent statistician confirmed the sample size following a re-estimation analysis, ensuring that the trial’s design remains statistically robust.

TRVI : 6.02 (-1.31%)
Healthcare - Medicine labratory by gorodenkoff via iStock
2 Breakout Growth Stocks With 200% Upside Potential Barchart - Fri Oct 18, 2024

The success of their pipelines could change the narrative for these emerging biotech companies.

ANRO : 2.23 (-0.89%)
TRVI : 6.02 (-1.31%)
$SPX : 5,299.13 (+0.44%)
Healthcare - stethoscope-with-injection-protective-mask-lying-over-medical-chart-SBI-300904603
5 Biotech Stocks Under $10 With Multibagger Potential Barchart - Fri Jul 12, 2024

As the biotech industry continues to redefine the healthcare landscape, here are five penny biotech stocks poised for meteoric growth in this evolving industry.

$SPX : 5,299.13 (+0.44%)
RZLT : 2.72 (+3.03%)
TRVI : 6.02 (-1.31%)
ELEV : 0.3800 (+14.91%)
CRDL : 0.9997 (-1.02%)
ADCT : 1.2200 (+5.17%)
Trevi Therapeutics Announces Results from Phase 2b/3 PRISM Open-Label Extension Study of Haduvioâ„¢ in Prurigo Nodularis PR Newswire - Fri Oct 13, 2023

/PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvioâ„¢ (oral...

TRVI : 6.02 (-1.31%)
Trevi Therapeutics to Participate in Upcoming September Events PR Newswire - Wed Sep 6, 2023

/PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvioâ„¢ (oral...

TRVI : 6.02 (-1.31%)
Trevi Therapeutics Announces Second Quarter 2023 Financial Results and Provides Business Update PR Newswire - Thu Aug 10, 2023

/PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvioâ„¢ (oral...

TRVI : 6.02 (-1.31%)
Trevi Therapeutics to Report Q2 2023 Financial Results and Provide a Corporate Update on August 10, 2023 PR Newswire - Thu Aug 3, 2023

/PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvioâ„¢ (oral...

TRVI : 6.02 (-1.31%)
Trevi Therapeutics to Participate in Upcoming August Events PR Newswire - Tue Aug 1, 2023

/PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvioâ„¢ (oral...

TRVI : 6.02 (-1.31%)
Trevi Therapeutics to Participate in Upcoming July Investor Events PR Newswire - Thu Jul 6, 2023

/PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvioâ„¢ (oral...

TRVI : 6.02 (-1.31%)

Barchart Exclusives

Is Silver Back on a Bullish Path? Barchart - 23 minutes ago
Silver is twice as volatile as gold, making it a highly speculative asset. In March, silver prices looked like they were heading for a test of the 2011 and 1980 highs, but April has been another story. Silver’s exclusion from tariffs caused a tidal wave of selling from April 2 through April 7. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro
Wed, Apr 23, 2025 5:00 PM UTC
Reserve Your Spot